SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
SanBio Total Liabilities (Quarterly): 13.01M for July 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
July 31, 2024 | 13.01M |
April 30, 2024 | 12.93M |
January 31, 2024 | 15.30M |
October 31, 2023 | 16.26M |
July 31, 2023 | 18.80M |
April 30, 2023 | 15.35M |
January 31, 2023 | 20.05M |
October 31, 2022 | 27.61M |
July 31, 2022 | 35.03M |
April 30, 2022 | 43.16M |
January 31, 2022 | 30.16M |
October 31, 2021 | 38.48M |
July 31, 2021 | 37.89M |
April 30, 2021 | 42.43M |
January 31, 2021 | 47.70M |
October 31, 2020 | 49.88M |
July 31, 2020 | 45.63M |
April 30, 2020 | 41.66M |
January 31, 2020 | 42.92M |
October 31, 2019 | 41.56M |
Date | Value |
---|---|
July 31, 2019 | 41.13M |
April 30, 2019 | 43.51M |
January 31, 2019 | 46.48M |
October 31, 2018 | 33.22M |
July 31, 2018 | 35.88M |
April 30, 2018 | 41.45M |
January 31, 2018 | 39.91M |
October 31, 2017 | 30.56M |
July 31, 2017 | 26.93M |
April 30, 2017 | 25.57M |
January 31, 2017 | 14.93M |
October 31, 2016 | 19.26M |
July 31, 2016 | 13.12M |
April 30, 2016 | 14.31M |
January 31, 2016 | 16.02M |
October 31, 2015 | 15.75M |
July 31, 2015 | 15.99M |
April 30, 2015 | 15.81M |
January 31, 2015 | 15.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
12.93M
Minimum
Apr 2024
49.88M
Maximum
Oct 2020
31.28M
Average
35.03M
Median
Jul 2022
Total Liabilities (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 53.58B |
Nxera Pharma Co Ltd | 543.75M |
PeptiDream Inc | 230.61M |
Healios KK | 90.39M |
AnGes Inc | 13.66M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 23.31M |
Shareholders Equity (Quarterly) | 10.30M |